Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors

Tuberculosis (TB) remains one of the leading causes of mortality worldwide. Hence, the identification of highly effective antitubercular drugs with novel modes of action is crucial. In this paper, we report the discovery and development of pyrrolo[1,5-a]pyrazine-based analogues as highly potent inhi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ACS Infect Dis
Glavni autori: Garzan, Atefeh, Willby, Melisa J., Ngo, Huy X., Gajadeera, Chathurada S., Green, Keith D., Holbrook, Selina Y. L., Hou, Caixia, Posey, James E., Tsodikov, Oleg V., Garneau-Tsodikova, Sylvie
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971065/
https://ncbi.nlm.nih.gov/pubmed/28192916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.6b00193
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items